AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find PXS-5505 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

PXS-5505
Also known as: Pxs-5505, 2409963-83-1, Do94e28wyw, 2-buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2z)-, Unii-do94e28wyw, Schembl21693445
Molecular Formula
C13H13FN2O2S
Molecular Weight
280.32  g/mol
InChI Key
DHXXLGDTPFPYRH-WDZFZDKYSA-N
FDA UNII
DO94E28WYW

Pan-LOX Inhibitor PXS-5505 is an orally available, small-molecule, irreversible inhibitor of all lysyl oxidases (LOX) family members, with potential antifibrotic activity. Upon oral administration, pan-LOX inhibitor PXS-5505 targets, binds to and inhibits the activity of all enzymes in the LOX family. This prevents the post-translational oxidative deamination of lysine residues on target proteins, including collagen and elastin, and reduces the formation of deaminated lysine (allysine), the formation of inter- and intramolecular cross-linkages and may prevent remodeling of the extracellular matrix (ECM), thereby reducing fibrotic tissue formation in certain chronic fibrotic diseases. LOX is often upregulated in fibrotic tissue and plays a key role in fibrosis.
1 2D Structure

PXS-5505

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(Z)-3-fluoro-4-quinolin-8-ylsulfonylbut-2-en-1-amine
2.1.2 InChI
InChI=1S/C13H13FN2O2S/c14-11(6-7-15)9-19(17,18)12-5-1-3-10-4-2-8-16-13(10)12/h1-6,8H,7,9,15H2/b11-6-
2.1.3 InChI Key
DHXXLGDTPFPYRH-WDZFZDKYSA-N
2.1.4 Canonical SMILES
C1=CC2=C(C(=C1)S(=O)(=O)CC(=CCN)F)N=CC=C2
2.1.5 Isomeric SMILES
C1=CC2=C(C(=C1)S(=O)(=O)C/C(=C/CN)/F)N=CC=C2
2.2 Other Identifiers
2.2.1 UNII
DO94E28WYW
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Pxs-5505

2. 2409963-83-1

3. Do94e28wyw

4. 2-buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2z)-

5. Unii-do94e28wyw

6. Schembl21693445

7. Glxc-25899

8. Dwn63831

9. Ex-a4912

10. Hy-138625

11. Cs-0159641

12. (z)-3-fluoro-4-quinolin-8-ylsulfonylbut-2-en-1-amine

13. (z)-3-fluoro-4-(quinolin-8-ylsulfonyl)but-2-en-1-amine

2.4 Create Date
2020-06-27
3 Chemical and Physical Properties
Molecular Weight 280.32 g/mol
Molecular Formula C13H13FN2O2S
XLogP30.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass280.06817700 g/mol
Monoisotopic Mass280.06817700 g/mol
Topological Polar Surface Area81.4 Ų
Heavy Atom Count19
Formal Charge0
Complexity430
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY